Sanket Pharmaceuticals Pvt Ltd, a active private limited company, was established on 01 December 1983 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24239MH1983PTC031464. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹1.53 M.
It upholds a compliant status. Its leadership includes Arti Rakesh Jain (Director), Rakesh Parasmal Jain (Director), Dinesh Parasmal Jain (Director). Past directors included Palak Dinesh Jain, Rakesh Parasmal Jain, Mishrimal Valchand Jain. It holds ₹1.90 M open charges and ₹5.00 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 196 A Tara Houseshop No 3 Dr Viegas Street Cavel X Lane - 8, Mumbai, Maharashtra, 400002.
U24239MH1983PTC031464
031464
01 December 1983
₹2.00 M
₹1.53 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Sanket Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arti Rakesh Jain | Director | 05 Feb 2021 | Current |
| Rakesh Parasmal Jain | Director | 26 Feb 2013 | Current |
| Dinesh Parasmal Jain | Director | 18 Dec 1995 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 May 2025 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2013 | Past |
| Pramod Abcsdd | Director | 28 Apr 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sanket Pharmaceuticals Pvt Ltd, for the financial year ended 2021, experienced significant reduction in revenue, with a 32.7% decrease. The company also saw a substantial fall in profitability, with a 26.47% decrease in profit. The company's net worth moved up by a moderate rise of 4.18%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Sanket Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,900,000.00
₹5,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 1995 | Sttae Bank Of India | ₹0.30 M | Open |
| 12 Jan 1988 | Sttae Bank Of India | ₹1.60 M | Open |
| 30 Mar 2001 | Corporation Bank | ₹5.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sanket Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sanket Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanket Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 30 Mar 2001 via Charge ID 90243514 with Corporation Bank was fully satisfied on 17 Nov 2025. was documented.
The activity Sanket Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Sanket Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
Arti Rakesh Jain was appointed as a Director was appointed as a Director on 05 Feb 2021 & has been associated with this company since 4 years 9 months . was recorded as a recent event.
The activity Rakesh Parasmal Jain was appointed as a Director was appointed as a Director on 26 Feb 2013 & has been associated with this company since 12 years 9 months . was completed.
A charge with Corporation Bank amounted to Rs. 5.00 M with Charge ID 90243514 was registered on 30 Mar 2001. was recorded as a recent event.
The CIN of Sanket Pharmaceuticals Pvt Ltd is U24239MH1983PTC031464.
Sanket Pharmaceuticals Pvt Ltd is headquartered at 196 A Tara Houseshop No 3 Dr Viegas Street Cavel X Lane - 8, Mumbai, Maharashtra, 400002.
Sanket Pharmaceuticals Pvt Ltd was incorporated on 01 December 1983.
The current directors of Sanket Pharmaceuticals Pvt Ltd are
The primary industry of Sanket Pharmaceuticals Pvt Ltd is Trade.
Sanket Pharmaceuticals Pvt Ltd is unlisted.
The authorized capital of Sanket Pharmaceuticals Pvt Ltd is ₹2.00 M, and the paid-up capital is ₹1.53 M.
The compliance status of Sanket Pharmaceuticals Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX